ALL >> Business >> View Article
Spain Introduces Measures To Reduce Public Deficit: What You Need To Know

The Spanish government has introduced provisional measures to the Corporate Income Tax in order to reduce public deficit this year. To achieve this objective, the government has fixed a 30% limit on net financial expenses deductibility of the EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization), maintained zero deprecation of assets for small and medium-sized enterprises (SMEs), and cut down annual overall limitation on tax credits.
The decree comes into effect from March 31, 2012 with a retroactive effect to taxable years starting from January 1, 2012.
Spain Tax Measures: Changes to Corporate Income Tax Regulations-
Replacing the thin capitalization regulations, the new ruling sets limit of up to 30% on net financial expenses deductibility of the EBITDA, carrying forward the undeducted expenses up to 18 years. If the net interest expense of a taxable year is lower than 30 %, the undeducted expense up to 30% of the EBITDA will be carried forward for 5 years. Deductible net expenses up to € 1 million being always deductible, companies which are not the part of a group of companies with ...
... specific limits, and credit institutions do not come under the purview of the 30% limit.
The new decree maintains free depreciation of assets for (SMEs) where the company maintains employee level. According to the new legislation, from March 31, 2012, no incentive will be applicable for assets obtained after this date; however, free depreciation will be applicable with certain limits for assets acquired before March 31, 2012.
To facilitate promotion of Research & Development (R&D), environment and other activities, the new ruling has cut down the annual overall limitation on tax credits to 25% of the corporate income tax due minus domestic and international tax credit and discounts. In case R&D tax credits cross 10% of the tax due, the limit is reduced to 50%. The reinvestment tax credit that was excluded before has been included for calculation of the limits. With the intention of offsetting the effects of these provisional methods, carry forward period of unused tax credits has been increased to 15 years. However, for R&D tax credits, the carry forward limit is increased from 15 to 18 years.
Having a trusted service provider on your side who can keep you up to date with the ever-changing laws and regulations can be of great help in your international business expansion plan. Professional experts have firsthand experience of the existing environments, and can impart extensive assistance on various areas of your business like international financial accounting, regulatory filings, to name a few.
Know more on: tax for expats & eu vat
Add Comment
Business Articles
1. Stem-xpert At Web Summit Qatar 2025, Pursuing Innovative Solutions In Stem-as-a-serviceAuthor: stem-xpert
2. Deepseek’s Rapid Rise: Disrupting The Ai Market Amid Controversy
Author: Iconic success
3. Reimagining Customer Services With Microsoft Dynamics 365 Implementation
Author: Maria
4. Upcoming Developments In Ss Flanges: Possible Effects On Different Industries
Author: Neelam Forge India
5. Mg Hector 5 Seater Price In Chennai: A Detailed Review
Author: balaji
6. Mg Hector Ev Price In Chennai: A Comprehensive Overview
Author: balaji
7. Spring Marketing Trends: How Print And Video Can Refresh Your Brand
Author: Devin Herz
8. Auto Transport Services In South Carolina
Author: Secure Car Shipping
9. Authentication Of Australian Certificates In Canada: A Complete Guide
Author: anzilanx
10. Low Maintenance Plants For Home Landscaping
Author: Apunga Landscapes
11. The Ultimate Guide To Rocking Chairs – Comfort, Style, And Elegance
Author: tushar
12. Bioethanol Market Size Insights Forecast 2024-2030
Author: Nilam Jadhav
13. Touffy Fabric Upholstered Rocking Chair – The Perfect Blend Of Comfort And Elegance
Author: tushar
14. Maximizing Efficiency: Why Small Businesses Should Outsource Bookkeeping And Financial Services
Author: KMK Ventures Pvt Ltd
15. Big Patient Data And The Future Of Real World Evidence: Learnings From Biotechx 2024
Author: Industry Chronicle